Holen Sie sich die Stockscreener-App
54.29
1.25%
0.67
Handel nachbörslich:
54.00
-0.29
-0.53%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TGTX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$53.62
Offen:
$54.17
24-Stunden-Volumen:
1.66M
Relative Volume:
0.81
Marktkapitalisierung:
$8.31B
Einnahmen:
$700.35M
Nettoeinkommen (Verlust:
$461.90M
KGV:
18.92
EPS:
2.8696
Netto-Cashflow:
$-14.19M
1W Leistung:
-5.47%
1M Leistung:
-4.59%
6M Leistung:
+61.91%
1J Leistung:
+48.09%
1-Tages-Spanne:
$53.15
$54.98
1-Wochen-Bereich:
$53.15
$57.66
52-Wochen-Spanne:
$26.76
$59.30
Tg Therapeutics Inc Stock (TGTX) Company Profile
Firmenname
Tg Therapeutics Inc
Sektor
Branche
Telefon
(212) 554-4484
Adresse
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Compare TGTX vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TGTX
Tg Therapeutics Inc
|
54.29 | 8.79B | 700.35M | 461.90M | -14.19M | 2.8696 |
VRTX
Vertex Pharmaceuticals Inc
|
504.73 | 127.93B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
190.01 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
735.20 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.21 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.64 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-06 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-07-10 | Fortgesetzt | Goldman | Neutral |
| 2024-10-29 | Eingeleitet | TD Cowen | Buy |
| 2023-08-02 | Hochstufung | Goldman | Sell → Neutral |
| 2023-06-26 | Fortgesetzt | Jefferies | Buy |
| 2022-05-20 | Eingeleitet | BofA Securities | Underperform |
| 2022-02-23 | Bestätigt | B. Riley Securities | Buy |
| 2021-11-15 | Herabstufung | Goldman | Neutral → Sell |
| 2021-04-20 | Eingeleitet | Goldman | Neutral |
| 2021-04-19 | Bestätigt | H.C. Wainwright | Buy |
| 2020-09-01 | Eingeleitet | JP Morgan | Overweight |
| 2020-08-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-05 | Eingeleitet | Evercore ISI | Outperform |
| 2020-01-17 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-27 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-02-06 | Fortgesetzt | Jefferies | Buy |
| 2018-09-25 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2018-03-09 | Bestätigt | B. Riley FBR, Inc. | Buy |
| 2017-12-01 | Fortgesetzt | B. Riley FBR, Inc. | Buy |
| 2017-11-14 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-04-25 | Eingeleitet | Jefferies | Buy |
| 2017-03-06 | Bestätigt | FBR & Co. | Outperform |
| 2016-10-06 | Fortgesetzt | Brean Capital | Buy |
| 2016-05-27 | Eingeleitet | SunTrust | Buy |
| 2015-12-01 | Eingeleitet | FBR Capital | Outperform |
| 2015-09-09 | Eingeleitet | Raymond James | Strong Buy |
| 2015-08-12 | Fortgesetzt | H.C. Wainwright | Buy |
| 2015-06-19 | Bestätigt | Brean Capital | Buy |
| 2014-12-11 | Bestätigt | ROTH Capital | Buy |
| 2014-12-10 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Tg Therapeutics Inc Aktie (TGTX) Neueste Nachrichten
TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance
Top Generate Biomedicines (GENB) Competitors 2026 - MarketBeat
TG Therapeutics, Inc. (TGTX) Stock forecasts - Yahoo Finance Australia
After tax other income/expense of TG Therapeutics, Inc. – HAN:NKB2 - TradingView
TG Therapeutics, Inc. Revenue Breakdown – HAN:NKB2 - TradingView
NKB2 Forecast — Price Target — Prediction for 2027 - TradingView
Investigation launched into TG Therapeutics' of... - Pluang
Kuehn Law Encourages Investors of TG Therapeutics, Inc. to Contact Law Firm - Morningstar
TGTX Stock Rises On Wall Street Price Target Hike, New Schizophrenia Trial Launch - Stocktwits
TG Therapeutics, Inc. (TGTX) Options ChainYahoo Finance - ca.finance.yahoo.com
TG Therapeutics, Inc. (TGTX) Stock Price, News, Quote & History - Yahoo! Finance Canada
TG Therapeutics Inc (TGTX) Stock Price Today: $56.12 - Pluang
(TGTX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
TG Therapeutics, Inc. (TGTX) Latest Stock News & Headlines - Yahoo Finance
TG Therapeutics (NASDAQ:TGTX) Combines Strong Growth With a Tight Technical Breakout Setup - ChartMill
TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 22.59% Upside Potential in the Biotech Sector - DirectorsTalk Interviews
TG Therapeutics Inc (TGTX) Stock Price, Quote, News & History - Benzinga
TGTX 2-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages TG Therapeutics (TGTX) Investors with Losses to Contact Firm's Attorneys Before Sept. 16th Deadline in Securities Fraud Class Action - TMX Newsfile
TG Therapeutics Eyes $1B Run Rate as BRIUMVI Gains MS Market Share - TradingView
TG Therapeutics (TGTX) Could Be 19% Undervalued After Its Recent Rebound - Yahoo Finance
TG Therapeutics (TGTX) Stock May Be Undervalued On Its Earnings Story - Simply Wall Street
Insider Decision: Laurence N Charney Offloads $274K Worth Of TG Therapeutics Stock - Benzinga
Tax-related share sale by TG Therapeutics (TGTX) director - stocktitan.net
TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Gem With A 29% Upside Potential - DirectorsTalk Interviews
TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - 富途牛牛
TGTX Stock Continues Rally For 8 Straight Sessions On New BRIUMVI Clinical Data - Stocktwits
TGTX Stock On Track For Best Day In 3.5 Months Amid Fresh Buyout Rumors - Stocktwits
Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st
TG Therapeutics (NASDAQ: TGTX) director plans $274,794.08 stock sale - Stock Titan
TG Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference - Quiver Quantitative
TG Therapeutics at Cantor conference: briumvi gains momentum By Investing.com - Investing.com Canada
TGTX: BRIUMVI targets $1B+ run rate, expanding with subQ and simplified dosing, backed by strong IP - TradingView
TG Therapeutics (TGTX) to Report Q2 Results: Wall Street Expects Earnings Growth - Eastern Progress
TG Therapeutics, Inc. (TGTX) Stock Analysis: Unveiling a 24.52% Upside Potential in the Biotech Sector - DirectorsTalk Interviews
TG Therapeutics to Participate in the Cantor Global Healthcare Conference - manilatimes.net
B. Riley Securities Remains a Buy on TG Therapeutics (TGTX) - The Globe and Mail
(TGTX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
IBD Stock Of The Day, TG Therapeutics, Eyes Breakout After Topping Early Buy Point - Investor's Business Daily
TG Therapeutics (TGTX) Up 15.1% Since Last Earnings Report: Can It Continue? - finance.yahoo.com
B. Riley Securities Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $86 - Moomoo
Finanzdaten der Tg Therapeutics Inc-Aktie (TGTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):